Industry-sponsored negative trials and the potential pitfalls of post hoc analysis.
Tribble
Curtis G
CG
Department of Surgery, University of Florida, PO Box 100286, Gainesville, FL 32610, USA. curt.tribble@surgery.ufl.edu
D000368:Aged; D016001:Confidence Intervals; D017023:Coronary Angiography; D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000379:methods; D023903:Coronary Restenosis / Q000517:prevention & control; D023921:Coronary Stenosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004345:Drug Industry / Q000191:economics*; D005260:Female; D005376:Financial Management; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D011182:Postoperative Care; D011300:Preoperative Care; D011336:Probability; D011732:Pyridoxal Phosphate / Q000008:administration & dosage*; D012016:Reference Values; D018570:Risk Assessment; D012720:Severity of Illness Index; D016019:Survival Analysis; D016896:Treatment Outcome; D014803:Vitamin B Complex / Q000008:administration & dosage*
D014803:Vitamin B Complex; D011732:Pyridoxal Phosphate